Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mrinal Y Shah

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Genetics|March 30, 2011
DNMT3A mutations in acute myeloid leukemiaMrinal Y Shah, Jonathan D Licht
Therapeutic Advances in Hematology|April 24, 2013
Epigenetic therapy of hematological malignancies: where are we now?Relja Popovic, Mrinal Y Shah, Jonathan D Licht
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
Cell Reports|October 19, 2017
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibitionTeresa Ezponda, Daphné Dupéré-Richer, Christine M Will, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Genetics|March 30, 2011
DNMT3A mutations in acute myeloid leukemiaMrinal Y Shah, Jonathan D Licht
Therapeutic Advances in Hematology|April 24, 2013
Epigenetic therapy of hematological malignancies: where are we now?Relja Popovic, Mrinal Y Shah, Jonathan D Licht
Cancer Research|July 1, 2010
DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesisMrinal Y Shah, Aparna Vasanthakumar, Natalie Y Barnes, et al.
The New England Journal of Medicine|October 24, 2024
CRISPR-Based Therapy for Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Markus Magerl, et al.
Cell Reports|October 19, 2017
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibitionTeresa Ezponda, Daphné Dupéré-Richer, Christine M Will, et al.
Plos Genetics|September 5, 2014
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylationRelja Popovic, Eva Martinez-Garcia, Eugenia G Giannopoulou, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Pageof 1